ÆüËÜÇÀ·Ý²½³Ø²ñ 2021ǯÅÙÂç²ñ¥×¥í¥°¥é¥à¸¡º÷

¥ª¥ó¥é¥¤¥óŸ¼¨²ñ (¥í¥°¥¤¥ó¤¬É¬ÍפǤ¹)
½ªÎ»¤·¤Þ¤·¤¿
¥×¥í¥°¥é¥à½¸PDF ´ë¶ÈÀâÌÀ²ñ
½ªÎ»¤·¤Þ¤·¤¿
¿Ê¹ÔÃæ¤Î¥×¥í¥°¥é¥à°ìÍ÷
½ªÎ»¤·¤Þ¤·¤¿
Âç²ñ¥È¥Ã¥×¥Ú¡¼¥¸¤ËÌá¤ë
Âç²ñ¥×¥í¥°¥é¥à½¸¡¦Âç²ñ¹Ö±éÍ׻ݽ¸¡ÎPDF¡Ï¤ÎÊѹ¹ (¹¹¿·¡§3/24)
¼ø¾Þ¼°¡¦¼õ¾Þ¹Ö±éÆ°²è¤¬¸ø³«¤µ¤ì¤Þ¤·¤¿¡£
¢¨¸ø³«´ü´Ö¡§2021ǯ5·î14Æü¡Á2022ǯ2·îËöÆü¤Þ¤Ç
¿ä¾©¥Ö¥é¥¦¥¶¡§Chrome¡¢FireFox¡¢Edge¡¢Safari
(Internet Explorer¤Ç¤ÏÀµ¤·¤¯É½¼¨¤µ¤ì¤Ê¤¤¾ì¹ç¤¬¤¢¤ê¤Þ¤¹)
2F07-17
°ìÈֱ̹é
¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à F
¥·¥ê¥Ó¥Ë¥ó¤Î¹âµ¡Ç½²½¤òÌܻؤ·¤¿ÁÏÌô¸¦µæ
Design, synthesis, and biological activity of conformationally restricted analogues of silibinin
¡û¿åÌî ÈþÎï1¿¹ °ì·û1ÅÚ²° ·½Êå1,3üâÌÚ ¹§»Î2»°ß· δ»Ë3½Ð¿å ÍDzð3¼Æ¾Â ¼Á»Ò1Ê¡¸¶ ·é1
¡ûMirei MIZUNO1 Kazunori MORI1 Keisuke TSUCHIYA1,3 Takashi TAKAKI2 Takashi MISAWA3 Yosuke DEMIZU3 Motoko SHIBANUMA1 Kiyoshi FUKUHARA1
1¾¼ÏÂÂçÌô¡¢2¾¼ÏÂÂç°å¡¢3¹ñ±Ò¸¦
1Sch. of pharm.,Showa Univ., 2Sch. of med.,Showa Univ., 3NIHS
silibinin / catechin / Alzheimer's disease

Í×»ÝËÜʸ¤Ï¥È¥Ã¥×¥Ú¡¼¥¸¤«¤é¥í¥°¥¤¥ó¤ò¤·¤Æĺ¤¯¤Èɽ¼¨¤µ¤ì¤Þ¤¹¡£